7/12/2024 | IGLM | Takeda Pharmaceutical prices tender offer for 2026 notes
|
7/11/2024 | IGLM | Takeda Pharmaceutical tender offers oversubscribed at early deadline
|
6/28/2024 | IGLM | Takeda Pharmaceutical ups cap in tender offers to $1.5 billion
|
6/28/2024 | IG | New Issue: Takeda Pharmaceutical details $3 billion of notes in four parts
|
6/28/2024 | BKIG | S&P assigns BBB+ to Takeda notes
|
6/27/2024 | IG | New Issue: Takeda Pharmaceutical prices $3 billion of notes in four parts
|
6/27/2024 | IGLM | Takeda Pharmaceutical starts tender offers for up to $1 billion notes
|
6/26/2023 | IG | Moody’s raises Takeda ratings
|
9/28/2022 | IGLM | Takeda Pharmaceutical calls $1 billion of 4.4% senior notes due 2023
|
9/27/2021 | IG | Moody's alters Takeda view to positive
|
6/1/2021 | IG | S&P turns Takeda view to stable
|
4/19/2021 | IGLM | Takeda Pharmaceutical to redeem early remaining 2.45% notes due 2022
|
2/26/2021 | IGLM | Takeda Pharmaceutical redeems $300 million of 2.45% senior notes due 2022
|
7/2/2020 | IG | Market Commentary: Steady post-holiday high-grade supply eyed; corporate inflows climb; Takeda, Mondelez firm
|
7/2/2020 | IG | Market Commentary: Morning Commentary: High-grade issuers quiet ahead of holiday; inflows remain strong
|
7/1/2020 | IG | Market Commentary: Pre-holiday investment-grade supply quiets; credit spreads firm; Takeda notes mostly better
|
7/1/2020 | IG | Market Commentary: Morning Commentary: High-grade supply quiets; Jabil holds fixed income investor calls
|
6/30/2020 | IG | Market Commentary: Mondelez, Societe Generale, Guardian Life, EBRD in primary; June deal supply heavy
|
6/30/2020 | IG | Market Commentary: Morning Commentary: Societe Generale, Mondelez, Guardian Life, EBRD plan primary tap
|
6/30/2020 | IG | New Issue: Takeda Pharmaceutical details $7 billion of notes in four parts
|
6/29/2020 | IG | Market Commentary: Takeda, Sumitomo Mitsui, MetLife Global, Equitable Financial, AEP, AIG price; EBRD on deck
|
6/29/2020 | IG | New Issue: Takeda Pharmaceutical prices $7 billion of senior notes in four parts
|
6/29/2020 | IG | Market Commentary: Morning Commentary: Takeda, Sumitomo Mitsui, AEP, Equitable Financial offer notes
|
6/26/2020 | IG | Market Commentary: Lighter pre-holiday high-grade supply eyed; Takeda markets deal; flows rebound; bonds mixed
|
6/26/2020 | IG | Market Commentary: Morning Commentary: High-grade supply quiets; Takeda continues marketing; flows rebound
|
6/25/2020 | IG | Market Commentary: Intuit prices $2 billion notes; United upsizes; Takeda markets deal; inflows nearly double
|
6/25/2020 | BKIG | S&P rates Takeda notes BBB+
|
6/25/2020 | IG | Market Commentary: Morning Commentary: Intuit offers four tranches; United on deck; Takeda markets deal
|
6/25/2020 | BKIG | Moody’s assigns Takeda notes Baa2
|
6/25/2020 | IG | Takeda to price dollar-denominated fixed-rate notes in four tranches
|
3/2/2020 | IGLM | Takeda Pharmaceutical to reduce debt via $1.03 billion divestments
|
12/18/2019 | IG | New Issue: Takeda sells $4.46 billion notes due 2021, 2023, 2028
|
8/29/2019 | IGLM | Takeda Pharmaceutical redeems in full its 3.8% senior notes due 2020
|
1/8/2019 | IG | S&P lowers Takeda
|
12/17/2018 | IG | Moody's downgrades Takeda
|
11/21/2018 | IG | Market Commentary: Kommuninvest upsizes; light supply forecast; Takeda mixed; GATX firms; Comcast eases
|
11/21/2018 | IG | Market Commentary: Morning Commentary: Kommuninvest tightens spread on three-year issue; Comcast recovers
|
11/20/2018 | IG | Market Commentary: HSBC Bank Canada prices; Kommuninvest eyes deal; Barclays, Marriott ease; Kroger mixed
|
11/20/2018 | IG | Market Commentary: Morning Commentary: High-grade primary quiet after Takeda deal; no reported bonds on tap
|
11/20/2018 | IG | New Issue: Takeda Pharmaceutical details $5.5 billion of notes in four tranches
|
11/19/2018 | IG | Market Commentary: Takeda sells $5.5 billion; Wisconsin Public Service, GATX price; PG&E, DowDuPont stable
|
11/19/2018 | IG | New Issue: Takeda Pharmaceutical prices $5.5 billion of senior notes in four tranches
|
11/19/2018 | IG | Market Commentary: Morning Commentary: GATX, Wisconsin Public Service offer notes; Takeda remains on deck
|
11/16/2018 | IG | Market Commentary: Takeda offers dollar notes; thin supply forecast; bonds widen; PG&E, Volkswagen decline
|
11/16/2018 | IG | Takeda expected to price about $5 billion of notes in Nov. 19 week
|
11/16/2018 | IG | Moody’s gives Takeda notes A2
|
11/16/2018 | IG | Market Commentary: Morning Commentary: Takeda offers dollar notes following euro deal; bond flows negative
|
11/16/2018 | IG | Takeda plans seven-part dollar notes, sells €7.5 billion euro notes
|
11/16/2018 | IG | S&P rates Takeda's dollar notes A-, may downgrade to BBB+
|
11/14/2018 | IG | Market Commentary: DowDuPont prices $12.7 billion; Kilroy, World Bank sell green notes; bank paper widens
|
11/14/2018 | IG | Market Commentary: Morning Commentary: Kilroy offers notes; DowDuPont, Takeda on tap; Handelsbanken firms
|
11/13/2018 | IG | Market Commentary: Handelsbanken, Marriott, U.S. Bancorp, Boston Properties price; DowDuPont, Takeda eyed
|
11/13/2018 | IG | Market Commentary: Morning Commentary: DowDuPont, Marriott, Boston Properties on deck; Takeda deal eyed
|
11/13/2018 | IG | Takeda Pharmaceutical holds roadshow for $14 billion of euro and possible dollar notes
|
11/9/2018 | IG | Moody’s rates Takeda notes A2
|
11/9/2018 | IG | S&P downgrades Takeda, rates euro notes A-
|
11/8/2018 | IG | Market Commentary: ING Groep prices $1.25 billion; volume light; Takeda considers dollar-denominated deal
|
11/8/2018 | IG | Takeda Pharmaceutical to hold roadshow for euro notes and potential dollar-denominated deal
|
5/9/2018 | IG | Moody's lowers Takeda Pharmaceutical
|
5/9/2018 | BKIG | S&P reviews Shire, Takeda
|
7/13/2017 | IG | S&P gives A- to Takeda bonds
|
7/13/2017 | IG | Moody's rates Takeda notes A1
|
7/11/2017 | IG | Market Commentary: Scotiabank, ANZ, Municipality Finance price; deal calendar takes shape; Whole Foods firms
|
7/11/2017 | IG | New Issue: Takeda Pharmaceutical sells $500 million 2.45% notes due 2022 at 55 bps over Treasuries
|
2/27/2017 | IG | S&P downgrades Takeda
|
1/11/2017 | IG | S&P puts Takeda on watch
|
1/10/2017 | IG | Moody’s may downgrade Takeda
|
12/3/2014 | IG | Moody’s cuts five Japanese corporates to A1
|
10/21/2014 | IG | S&P downgrades Takeda to A+/A-1
|
7/10/2012 | IG | S&P rates Takeda bonds AA-
|
7/10/2012 | IG | Moody's rates Takeda notes Aa3
|
7/10/2012 | IG | Market Commentary: Pipeline open with Westpac, Sumitomo, ING, Penske in market; new issues tighten in secondary
|
7/9/2012 | IG | New Issue: Takeda Pharmaceutical prices $3 billion of bonds in three-, five-year tranches
|
7/9/2012 | IG | Market Commentary: Primary comes back to life as Monsanto, Cabot, Mitsubishi, Takeda price; bank, broker wider
|
3/13/2012 | IG | Moody's: Takeda bonds Aa3
|